学术探索
学术期刊
新闻热点
数据分析
智能评审

Cetuximab and cisplatin for chemotherapy refractory squamous cell cancer of the head and neck

被引：16
作者：
Burtness, B [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 24期
关键词：
D O I：
10.1200/JCO.2005.02.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5440 / 5442
页数：3
相关论文
共 13 条
  • [1] Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck
    Baselga, J
    Trigo, JM
    Bourhis, J
    Tortochaux, J
    Cortés-Funes, H
    Hitt, R
    Gascón, P
    Arnellal, N
    Harstrick, A
    Eckardt, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5568 - 5577
  • [2] BURTNESS BA, 2003, 2003 ANN AACR NCI EO
  • [3] Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
    Chung, KY
    Shia, J
    Kemeny, NE
    Shah, M
    Schwartz, GK
    Tse, A
    Hamilton, A
    Pan, D
    Schrag, D
    Schwartz, L
    Klimstra, DS
    Fridman, D
    Kelsen, DP
    Saltz, LB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1803 - 1810
  • [4] Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
    Cohen, EEW
    Rosen, F
    Stadler, WM
    Recant, W
    Stenson, K
    Huo, DZ
    Vokes, EE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1980 - 1987
  • [5] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    Cunningham, D
    Humblet, Y
    Siena, S
    Khayat, D
    Bleiberg, H
    Santoro, A
    Bets, D
    Mueser, M
    Harstrick, A
    Verslype, C
    Chau, I
    Van Cutsem, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) : 337 - 345
  • [6] EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND SURVIVAL IN UPPER AERODIGESTIVE TRACT CANCER
    DASSONVILLE, O
    FORMENTO, JL
    FRANCOUAL, M
    RAMAIOLI, A
    SANTINI, J
    SCHNEIDER, M
    DEMARD, F
    MILANO, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1873 - 1878
  • [7] Epidermal growth factor protects epithelial cells against Fas-induced apoptosis - Requirement for Akt activation
    Gibson, S
    Tu, S
    Oyer, R
    Anderson, SM
    Johnson, GL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17612 - 17618
  • [8] GRANDIS JR, 1998, J NATL CANCER I, V90, pB24
  • [9] Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck
    Herbst, RS
    Arquette, M
    Shin, DM
    Dicke, K
    Vokes, EE
    Azarnia, N
    Hong, WK
    Kies, MS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5578 - 5587
  • [10] Two EGF molecules contribute additively to stabilization of the EGFR dimer
    Lemmon, MA
    Bu, ZM
    Ladbury, JE
    Zhou, M
    Pinchasi, D
    Lax, I
    Engelman, DM
    Schlessinger, J
    [J]. EMBO JOURNAL, 1997, 16 (02) : 281 - 294
12